Loading…
Loading…
Structured register of government actions in the geoeconomic space — export controls, tariffs, sanctions, FDI screening, subsidies, industrial-policy laws — cross-referenced into the country, minerals, and ETF surface. Charter: docs/IPTM_CHARTER.md.
Severity 1-5 is the qualitative impact rating (1=minor, 5=structural). The bilateral-trade-grounded quant scorer is the next IPTM milestone. RBI (Register Breadth Index) is a complementary structural-breadth indicator from scripts/py/iptm/breadth.py; divergence between RBI and severity is itself informative (high-sev / low-RBI = strategic chokepoint; low-sev / high-RBI = broad but shallow). Every action has at least one primary source URL. Verify-or-don't-file. See also themes, timeline, graph, sankey, map, country exposure, sector exposure, material exposure (+ graph), weekly briefs, portfolio scan, escalation monitor, trans-shipment hubs. Internal triage tools (RSS-poller candidate feed, source-feed health) live under /admin/candidates + /admin/sources. Subscribe via Atom feed (accepts ?country=CN, ?material=lithium, ?issuer=BIS, ?type=export_control, ?etf=SOXX, ?company=NVDA, ?minSeverity=4, ?year=2026, ?q=…) or pull /api/iptm/actions.
On 2 April 2026 President Trump issued a Presidential Proclamation under Section 232 of the Trade Expansion Act of 1962 ("Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients into the United States") imposing a 100% ad valorem tariff on imports of patented pharmaceutical products listed in the FDA Orange Book and Purple Book, together with the active pharmaceutical ingredients (APIs) and key starting materials used to make them. The base rate takes effect at 12:01 a.m. EDT on 31 July 2026 for the 17 manufacturers identified in Annex III, and on 29 September 2026 for all other companies. The proclamation adopts findings of the Section 232 investigation initiated by the Department of Commerce on 14 April 2025 into pharmaceuticals and APIs as a national- security supply-chain risk. The instrument is structured around a multi-tier rate ladder rather than a flat tariff: concessionary 15% rates for EU/Japan/South Korea/Switzerland/Liechtenstein under reciprocal-deal tracks, 10% for the UK with a pathway to 0% under the pending UK pharmaceutical agreement, a "+20%" surcharge for companies operating under a Commerce-approved onshoring plan (until 2 April 2030), and a 0% pathway for companies that combine an approved onshoring plan with an MFN-pricing agreement with HHS (until 20 January 2029). Generics, biosimilars and their ingredients, orphan drugs, nuclear medicines, plasma-derived therapies, fertility treatments, and cell/gene therapies are carved out.
President Trump signed a Presidential Proclamation on 20 February 2026 invoking Section 122 of the Trade Act of 1974 (19 U.S.C. § 2132) to impose a temporary 10% ad-valorem import surcharge on articles imported into the United States, effective 12:01 a.m. EST on 24 February 2026. The proclamation was issued within hours of the US Supreme Court's 20 February 2026 ruling in Learning Resources, Inc. v. Trump, which held that the International Emergency Economic Powers Act (IEEPA) does not authorize the president to set tariffs and vacated the IEEPA-based reciprocal-tariff regime previously in effect. The Section 122 surcharge is statutorily limited to 150 days (terminates 24 July 2026 absent Congressional extension) and the statute caps any such surcharge at 15% ad valorem. Goods qualifying as USMCA originating from Canada or Mexico are exempt; CAFTA-DR textile/apparel articles meeting specified rules of origin are exempt; and a substantial product-exception list excludes critical minerals, energy products, certain pharmaceuticals, electronics, vehicles, aerospace products, specified agricultural goods, and goods already subject to Section 232 duties (the Section 122 duty does not stack on Section 232).
On 14 January 2026 President Trump issued a Presidential Proclamation under Section 232 of the Trade Expansion Act of 1962 imposing a 25% ad valorem tariff on imports of certain advanced computing chips and their derivative products, effective 12:01 a.m. EST on 15 January 2026. The measure adopts findings of the Section 232 investigation initiated 1 April 2025 (Department of Commerce report transmitted 22 December 2025) into semiconductors, semiconductor manufacturing equipment, and derivative products. Coverage is narrowly drawn to high-performance AI accelerators meeting specified technical parameters (publicly characterised as covering devices in the NVIDIA H200 / AMD MI325X performance tier), with broad use-based exemptions for chips going into US data centres, US R&D, US repairs, and other uses deemed to strengthen domestic supply chains.
Decree reforming various tariff fractions of the General Import and Export Duties Tariff (TIGIE), published in the Diario Oficial de la Federación on 29 December 2025 and in force 1 January 2026. The reform, approved by Congress as a statutory amendment to the LIGIE (Chamber of Deputies and Senate, Dec 2025) and signed by President Claudia Sheinbaum, raises MFN import duties to between 5% and 50% ad valorem on 1,463 tariff lines covering more than 20 chapters of the TIGIE, spanning automotive, auto parts, textiles, apparel, footwear, steel, aluminum, plastics, paper, leather, furniture, glass, toys, appliances and cosmetics. The increases apply only to goods originating in countries without a free trade agreement with Mexico — principally China, South Korea, India, Vietnam, Thailand, Brazil, Indonesia, Chinese Taipei, the UAE, and South Africa. The decree formalises at statutory level the September 2024 Sheinbaum executive order placing a 50% duty on finished passenger vehicles from non-FTA states and is framed by the Secretaría de Economía and SHCP as the operational tariff instrument of Plan México (2025-01-21).
At the APEC Busan summit on 30 October 2025, Presidents Trump and Xi reached the "Economic and Trade Arrangement Between the United States and the People's Republic of China," subsequently implemented on the US side by the executive order "Modifying Reciprocal Tariff Rates Consistent with the Economic and Trade Arrangement" (issued 4 November 2025; effective 12:01 am EST on 10 November 2025; published in the Federal Register on 7 November 2025 as 90 FR 50729 / 2025-19826) and on the Chinese side by a series of MOFCOM and State Council Tariff Commission announcements (notably MOFCOM 2025 No. 90 of 8–9 November 2025). The arrangement is structurally parallel to the already-filed US-Japan, US-Korea and US-Taiwan framework deals but uniquely material because it freezes the highest-stakes bilateral tariff and export-control confrontation of the post-2024 reset. Core US commitments: (i) reciprocal-tariff "additional ad valorem rate of duty" on PRC-origin goods reduced from a prior 20% IEEPA-fentanyl + 10% IEEPA-reciprocal stack to a 10% rate (i.e., the prior 24% / 34% scheduled escalation is suspended), extended through 10 November 2026; (ii) US BIS suspends the so-called "affiliates rule" expanding entity-list controls to majority-owned subsidiaries of listed Chinese firms; (iii) USTR pauses Section 301 maritime / shipbuilding / logistics countermeasures against Chinese vessels for one year. Core PRC commitments: (i) MOFCOM suspends for one year (until 10 November 2026) the 9 October 2025 extraterritorial rare-earth export-control package — including controls on REE processing equipment, lithium-battery manufacturing equipment, and superhard materials; (ii) PRC suspends retaliatory tariffs on a broad swath of US agricultural products through 31 December 2026; (iii) commitment to purchase ≥25 million metric tonnes of US soybeans annually in 2026-2028 and to resume sorghum and log imports; (iv) suspension of MOFCOM antitrust and "unreliable-entity" probes against named US semiconductor and chip-equipment companies; (v) cooperation on fentanyl precursor enforcement. The arrangement does not repeal underlying authorities (IEEPA tariffs, MOFCOM export-control list, Entity List) — it is a calibrated mutual freeze with a one-year sunset and quarterly review checkpoints.
President Trump signed Executive Order 14323, "Addressing Threats to the United States by the Government of Brazil," on 30 July 2025 (published in the Federal Register on 5 August 2025 as FR doc 2025-14896). Invoking IEEPA and the National Emergencies Act, the order declared a country- specific national emergency citing "policies, practices, and actions" of the Lula government — including the criminal prosecution of former president Jair Bolsonaro, asserted infringement of the free-expression rights of US persons via DSA-style platform-content rules, and retaliatory measures targeting US digital firms — as constituting an "unusual and extraordinary threat" to US national security, foreign policy, and economy. The EO imposed a 40% additional ad valorem duty on Brazilian-origin goods effective for entries on or after 12:01 a.m. EDT on 6 August 2025; stacked on top of the 10% baseline reciprocal rate from EO 14257/14326, the cumulative rate reached 50% for non- exempt goods. Annex I exempted civil aircraft and parts, orange juice, certain machinery, certain metals, and energy/energy products. The EO was amended on 20 November 2025 (effective for entries on or after 13 November 2025) to exempt 238+ HTSUS codes for agricultural products (beef, tropical produce, nuts, coffee, cocoa, cassava derivatives, etc.) following initial Trump-Lula bilateral negotiations on 6 October 2025. The IEEPA-tariff component was terminated by EO of 20 February 2026 ("Ending Certain Tariff Actions") within hours of the SCOTUS 6-3 ruling in *Learning Resources, Inc. v. Trump* holding that IEEPA does not authorize the imposition of tariffs.
President Trump signed Executive Order 14324, "Suspending Duty-Free De Minimis Treatment for All Countries," on 30 July 2025 (published in the Federal Register on 5 August 2025 as FR doc 2025-14897, 90 FR 37775). The order eliminated the Section 321(a)(2)(C) administrative exemption that had allowed shipments valued at $800 or less to enter the United States duty-free, applying the suspension to all countries of origin rather than the China/Hong Kong-only carve-out imposed earlier in 2025. DHS/CBP published a Notice of Implementation on 2 September 2025 (FR doc 2025-16802) modifying the Harmonized Tariff Schedule so that covered low-value goods must be entered via formal or informal ACE entry types and pay applicable duties; goods shipped through the international postal network were instead made subject to a new flat ad valorem or specific per-item duty rate set by HTSUS annex. The suspension took effect for entries on or after 12:01 a.m. EDT on 29 August 2025. A DHS/CBP rule published 24 June 2026 (FR doc 2026-12670) converted the non-postal suspension from time-limited to indefinite and closed the remaining international-postal-network exemption to formal/ informal entry procedures as well.
President Trump signed Proclamation 10962 on 30 July 2025, imposing a 50% Section 232 tariff on imports of semi-finished copper products (pipes, wires, rods, sheets, tubes, foils) and copper-intensive derivative products (cables, connectors, electrical components, pipe fittings) effective 12:01 a.m. ET on 1 August 2025. The proclamation also authorises the Commerce Secretary to impose a 25% domestic-sales requirement and export controls on high-quality copper scrap, and lays out a phased schedule for refined-copper tariffs (15% from 1 Jan 2027, 30% from 1 Jan 2028) contingent on a Commerce review report due 30 June 2026. Copper input materials (ores, concentrates, cathodes, anodes) and copper scrap itself are exempt from the 50% tariff. The original 90-day "inclusions" process for expanding the derivative list was terminated by a follow-on April 2026 proclamation that consolidated authority with Commerce + USTR.
On 10–11 May 2025 in Geneva, US Treasury Secretary Scott Bessent and USTR Jamieson Greer met with PRC Vice Premier He Lifeng and on 12 May 2025 issued the "Joint Statement on US-China Economic and Trade Meeting in Geneva," producing the first bilateral de-escalation of the post-2 April 2025 reciprocal-tariff stand-off. The agreement was implemented on the US side via Executive Order 14298 of 12 May 2025 ("Modifying Reciprocal Tariff Rates To Reflect Discussions With the People's Republic of China," published in the Federal Register 21 May 2025 as 90 FR 21831 / 2025-09297) and on the Chinese side via State Council Tariff Commission Announcement No. 4 of 2025. Effective 12:01 a.m. EDT on 14 May 2025, both sides suspended for 90 days (through 12 August 2025) the 24 percentage points of additional ad valorem duty layered on top of the prior 10% reciprocal rate, while the 10% reciprocal rate itself was retained. On the US side this reduced the headline reciprocal-tariff burden on PRC-origin goods from a 125% scheduled rate (under EOs 14259 and 14266) to 10%; combined with the still-in-force 20% IEEPA-fentanyl tariff under Executive Order 14195 (separately filed: `2025-02-01-us-trump-fentanyl-tariffs-canada-mexico-china`), the effective additional rate on most Chinese imports came down to ~30%. China made a parallel 24pp suspension on US-origin goods (from a 125% retaliatory rate to 10%) and additionally suspended non-tariff countermeasures imposed since 2 April 2025 (export controls, unreliable-entity designations, MOFCOM probes). The truce is structurally a calibrated freeze of the reciprocal-tariff ladder under the April 2025 regime, not a repeal: the underlying EO 14257 / IEEPA framework remains intact and was scheduled to re-engage at the 24pp escalated rate on 12 August 2025 absent further extension. The Geneva agreement is the precursor to the August 2025 Stockholm extension and the October 2025 Busan Economic and Trade Arrangement (separately filed: `2025-10-30-us-china-busan-economic-trade-arrangement`).
President Trump signed Executive Order 14257 on 2 April 2025 declaring a national emergency over US trade deficits and imposing a baseline 10% ad-valorem tariff on imports from nearly all trading partners effective 5 April, with higher country-specific "reciprocal" rates effective 9 April. The rate schedule was constructed from a formula tied to bilateral goods-trade deficits and ranged from 10% (UK, Singapore, Brazil, Australia, others) through 20% (EU), 24% (Japan), 25% (Korea), 32% (Taiwan, Indonesia, Switzerland), 34% (China, later raised to 84% then 125% during the April escalation), 46% (Vietnam), 49% (Cambodia). Multiple subsequent EOs paused the country-specific rates for 90 days for non-China destinations on 9 April while keeping the 10% baseline, pending bilateral negotiations.
President Trump signed Proclamation 10908 "Adjusting Imports of Automobiles and Automobile Parts Into the United States" on 26 March 2025, invoking Section 232 of the Trade Expansion Act of 1962 to impose a 25% ad valorem tariff on imports of finished passenger vehicles and light trucks effective 12:01 a.m. EDT on 3 April 2025, with the duty extended to key automobile parts (engines and engine parts, transmissions and powertrain components, electrical components) effective 12:01 a.m. EDT on 3 May 2025. USMCA-origin automobiles receive an interim deduction equal to the value of US-origin content; USMCA-origin parts that satisfy the agreement's rules of origin are temporarily exempt from the parts duty pending a Commerce-administered process. The proclamation is the first Section 232 instrument applied to finished automobiles in US history and the largest-by-trade-volume Section 232 measure of the second Trump administration, covering roughly USD 460 billion of annual auto and auto-parts imports.
President Trump signed two Presidential Proclamations on 11 February 2025 reinstating a universal 25% ad-valorem tariff on all steel-mill products and raising the aluminum tariff from 10% to 25% on all imports into the United States, effective 12 March 2025. The proclamations revoked every bilateral exclusion and quota arrangement negotiated by the Biden administration with the EU, UK, Japan, Korea, Australia, and others under the 2021-2022 "alternative measures" frameworks, returning all trading partners to the baseline Section 232 rate without product-level or country-level carve-outs.
President Trump signed three Executive Orders on 1 February 2025 (EO 14193, 14194, 14195) declaring national emergencies under IEEPA over the cross-border flow of fentanyl + illegal migration, and using that authority to impose new tariffs: 25% on imports from Canada (with a reduced 10% rate on Canadian energy products), 25% on imports from Mexico, and an additional 10% on imports from China (separate from pre-existing Section 301 + Section 232 tariffs). The tariffs took effect 4 February 2025. On 3 February 2025 the administration announced a 30-day pause for both Canada and Mexico following bilateral border-enforcement commitments; the China tariff was not paused. China responded 4 February with retaliatory tariffs of 15% on US LNG/coal/farm equipment and additional measures. The package set the precedent for the broader 2 April 2025 "Liberation Day" reciprocal-tariff regime (filed: 2025-04-02-us-trump-reciprocal-tariff-regime).
Lei nº 9.019, signed 30 March 1995 by President Fernando Henrique Cardoso and published in the Diário Oficial da União 31 March 1995, is the foundational Brazilian statute transposing the WTO Antidumping Agreement (ADA) and Subsidies and Countervailing Measures Agreement (SCM Agreement) into domestic law following Brazil's signature of the Marrakesh Agreement on 15 April 1994. The law grants DECOM (within SECEX/MDIC) authority to conduct AD/CVD investigations and injury determinations, and CAMEX/GECEX authority to impose provisional and definitive duties. It has been amended by Lei 10.611/2002, Lei 12.270/2010, and Lei 14.609/2023 (anti-circumvention + electronic-investigation procedures), and is the statutory parent of Brazil's entire modern trade-remedy architecture including the filed GECEX implementing instruments on carbon steel, polyester fibres, and optical fibre.
Mexico's Ley de Comercio Exterior (Foreign Trade Act, LCE), published in the Diario Oficial de la Federación on 27 July 1993 and entering into force 28 July 1993, is the foundational statute governing Mexico's entire external trade regulatory architecture. The LCE establishes the legal authority for the SECOFI/SE-administered antidumping (AD), countervailing duty (CVD), and safeguard investigation regime (Titles V–VII); the TIGIE tariff-schedule and tariff-classification framework; the IMMEX maquila and PROSEC sectoral-promotion programs; rules of origin for USMCA and other preferential trade agreements; and Mexico's export- licensing and strategic-material restriction framework. The LCE has been amended repeatedly through 2021 and remains the overarching parent authority for all Mexican trade-remedy proceedings administered by UPCI (Unidad de Prácticas Comerciales Internacionales) under the Secretaría de Economía.
The Trade Act of 1974 (Pub. L. 93-618, 88 Stat. 1978), signed into law by President Ford on 3 January 1975 and codified principally at 19 U.S.C. §§ 2101–2497b, is the foundational US statute authorising the executive branch to respond to foreign unfair trade practices and to negotiate trade agreements. Title III (§§ 2411–2420), universally known as "Section 301," empowers the United States Trade Representative to investigate foreign acts, policies, or practices that violate trade agreements or are unjustifiable, unreasonable, or discriminatory and burden or restrict US commerce, and — upon an affirmative finding — to impose tariffs, import restrictions, denial of trade-agreement benefits, or other retaliatory measures. Section 301 is the legal basis for every major US unfair-trade-practice retaliation action filed in the IPTM register, including the 2018–2024 China tariff Lists 1–4 and their 2024 escalation, the 2025 China maritime/shipbuilding investigation, the 2025 Brazil investigation, and the 2026 structural-excess-capacity investigation against sixteen economies.
The Trade Expansion Act of 1962 (Pub. L. 87-794, 76 Stat. 872), signed into law by President Kennedy on 11 October 1962 and codified at 19 U.S.C. §§ 1801–1991, is the foundational US statute granting the executive branch broad authority to negotiate tariff reductions and, critically via Section 232 (19 U.S.C. § 1862), to adjust imports of any article found by the Secretary of Commerce to threaten to impair national security. Section 232 empowers the President — on receipt of a Commerce Department affirmative national-security finding — to impose tariffs, quantitative restrictions, or other import-adjustment measures without congressional approval or WTO-required safeguard procedures. From 1962 to the Trump Administration's 2018–2026 wave of Section 232 Proclamations, the authority was invoked primarily for petroleum and machine-tool imports; since 2018 it has become the legal vehicle for national-security tariffs on steel, aluminum, automobiles, copper, timber, critical minerals, semiconductors, and pharmaceuticals, with 19+ IPTM-filed implementing instruments citing Pub. L. 87-794 / 19 U.S.C. § 1862 as their statutory parent.
The Tariff Act of 1930 (Pub. L. 71-361, 46 Stat. 590, codified principally at 19 U.S.C. Chapter 4) is the foundational US statute governing customs revenue, tariff classification, and trade-remedy administration, signed by President Hoover on 17 June 1930. The Act's original Smoot-Hawley tariff schedules are widely cited as a contributing factor to the contraction of global trade during the Great Depression, but the statute's enduring significance lies in its creation of (i) the Title VII antidumping (AD) and countervailing duty (CVD) proceedings framework administered jointly by Commerce ITA and the USITC — the parent authority for every US AD/CVD order in force today — and (ii) Section 337 (19 U.S.C. §1337), the USITC unfair-import and IP-exclusion-order regime under which ~50+ active investigations are conducted annually against semiconductor, biotech, electronics, and other technology imports. Title I's customs-valuation and HTSUS tariff- classification framework underpins all US import-revenue collection; Title VII AD/CVD authority was updated by the GATT Tokyo Round Trade Agreements Act of 1979 and the Uruguay Round Agreements Act of 1994 (URAA) to align with WTO Antidumping and Subsidies Agreements.